Antibody designed to recognize pathogens of Alzheimer’s disease

loading...

Alzheimer's disease
PET scan of a human brain with Alzheimer’s disease. Credit: public domain

Researchers have found a way to design an antibody that can identify the toxic particles that destroy healthy brain cells—a potential advance in the fight against Alzheimer’s disease.

Their method is able to recognise these toxic particles, known as amyloid-beta oligomers, which are the hallmark of the , leading to hope that new diagnostic methods can be developed for Alzheimer’s disease and other forms of dementia.

The team, from the University of Cambridge, University College London and Lund University, designed an antibody which is highly accurate at detecting toxic oligomers and quantifying their numbers. Their results are reported in the Proceedings of the National Academy of Sciences (PNAS).

“There is an urgent unmet need for to recognise oligomers—which play a major role in Alzheimer’s disease, but are too elusive for standard antibody discovery strategies,” said Professor Michele Vendruscolo from Cambridge’s Centre for Misfolding Diseases, who led the research. “Through our innovative design strategy, we have now discovered to recognise these toxic particles.”

Dementia is one of the leading causes of death in the UK and costs more than £26 billion each year, a figure which is expected to more than double in the next 25 years. Estimates put the current cost to the global economy at nearly £1 trillion per year.

Alzheimer’s disease, the most prevalent form of dementia, leads to the death of nerve cells and tissue loss throughout the brain, resulting in memory failure, personality changes and problems carrying out daily activities.

Abnormal clumps of proteins called oligomers have been identified by scientists as the most likely cause of dementia. Although proteins are normally responsible for important cell processes, according to the amyloid hypothesis, when people have Alzheimer’s disease these proteins -including specifically amyloid-beta proteins—become rogue and kill healthy nerve cells.

Proteins need to be closely regulated to function properly. When this quality control process fails, the proteins misfold, starting a chain reaction that leads to the death of brain cells. Misfolded proteins form abnormal clusters called plaques which build up between brain cells, stopping them from signalling properly. Dying brain cells also contain tangles, twisted strands of proteins that destroy a vital cell transport system, meaning nutrients and other essential supplies can no longer move through the .

There have been over 400 clinical trials for Alzheimer’s disease, but no drug that can modify the course of the disease has been approved. In the UK, dementia is the only condition in the top 10 causes of death without a treatment to prevent, stop, or slow its progression.

“While the amyloid hypothesis is a prevalent view, it has not been fully validated in part because amyloid-beta oligomers are so difficult to detect, so there are differing opinions on what causes Alzheimer’s disease,” said Vendruscolo. “The discovery of an antibody to accurately target oligomers is, therefore, an important step to monitor the progression of the disease, identify its cause, and eventually keep it under control.”

The lack of methods to detect oligomers has been a major obstacle in the progress of Alzheimer’s research. This has hampered the development of effective diagnostic and therapeutic interventions and led to uncertainty about the amyloid hypothesis.

“Oligomers are difficult to detect, isolate, and study,” said Dr. Francesco Aprile, the study’s first author. “Our method allows the generation of antibody molecules able to target oligomers despite their heterogeneity, and we hope it could be a significant step towards new diagnostic approaches.”

The method is based on an approach for antibody discovery developed over the last ten years at the Centre for Misfolding Diseases. Based on the computational assembly of antibody-antigen assemblies, the method enables the design of antibodies for antigens that are highly challenging, such as those that live only for a very short time.

By using a rational design strategy that enables to target specific regions, or epitopes, of the oligomers, and a wide range of in vitro and in vivo experiments, the researchers have designed an antibody with at least three orders of magnitude greater affinity for the oligomers over other forms of amyloid-beta. This difference is the key feature that enables the antibody to specifically quantify oligomers in both in vitro and in vivo samples.

The team hopes that this tool will enable the discovery of better drug candidates and the design of better clinical trials for people affected by the debilitating disease. They also co-founded Wren Therapeutics, a spin-out biotechnology company based at the Chemistry of Health Incubator, in the recently opened Chemistry of Health building, whose mission it is to take the ideas developed at the University of Cambridge and translate them into finding new drugs to treat Alzheimer’s disease and other misfolding disorders.

The antibody has been patented by Cambridge Enterprise, the University’s commercialisation arm.


Scientists reveal ground-breaking plan to target cause of Alzheimer’s disease


More information:
Francesco A. Aprile el al., “Rational design of a conformation-specific antibody for the quantification of Aβ oligomers,” PNAS (2020). www.pnas.org/cgi/doi/10.1073/pnas.1919464117

Citation:
Antibody designed to recognize pathogens of Alzheimer’s disease (2020, May 25)
retrieved 25 May 2020
from https://medicalxpress.com/news/2020-05-antibody-pathogens-alzheimer-disease.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



loading...
(Visited 1 times, 1 visits today)

Related posts:

Diabetische Nephropathie: Studien zur Proteomanalyse zeigen keinen Nutzen
Simulations with actors prepare nurses for the demands of their profession
Trump Administration Signals Formal Withdrawal From W.H.O.
WHO: Ausmaß von Luftübertragung von Coronaviren noch unklar
French PM defends promotion of minister accused of rape after feminist backlash
Why some people won't wear face masks even if told to
Tumor-Therapie im Spiegel: Checkpoint-Blockade durch D-Peptid für Immuntherapie gegen Krebs
Team creates a collaborative platform to streamline brain metastasis research
Neue internationale Empfehlungen für nicht tuberkulöse Mykobakterien veröffentlicht
Deconstructing glioblastoma complexity reveals its pattern of development
Rodin Museum in Paris sells bronzes to make up for crippling shutdown
DGEM-Vorstand: Bosy-Westphal aus Kiel ist neue Vorsitzende
WHO says Sri Lanka and Maldives eliminate measles, rubella
Neutralisierende Antikörper im Kampf gegen COVID-19
Trump sees Kanye West White House bid as ‘trial run’ for 2024
France rules out 'total lockdown' in case of new COVID-19 spike
EU: Corona verändert Drogenkonsum - Biermann Medizin
Men and younger adults less active in lockdown
Erster COVID-19-Patient in Deutschland erfolgreich mit neuer Zwerchfelltherapie behandelt
Nurse misreads symptoms of her own heart attack
Neues Studienzentrum: Bewegungsstörungen im Fokus
New French PM Castex pledges €7.5 billion for hospital staff in wake of pandemic
Proposed study would test at-home screening for HPV and cervical cancer
Thousands protest in Belgrade as Serbia reimposes Covid-19 curfew
A dangerous antibiotic-resistant bacteria may now lurk in U.S. water, soil
China transforms Hong Kong hotel into new security agency headquarters
COVID-19 outbreaks at meat processing plants are hitting minorities hard
FBI chief says China is blackmailing dissenters in US to force them back home
Study explores if insurance is keeping pace with trends in targeted cancer therapy
Two studies look at COVID-19 in patients who have received kidney transplants or are undergoing dial...
Trump's niece brands him a liar and a cheat in new book, White House cries foul
Twins joined at head separated at Vatican pediatric hospital
Increase in delirium, rare brain inflammation and stroke linked to COVID-19
Trump moves to formally withdraw US from World Health Organisation
Chile tops 300,000 virus cases, plans to lift lockdown
Welcome, Robin the AI robot
Revamped French government takes office, tasked with restoring coronavirus-hit economy
Herzinfarktpatienten während der Coronavirus-Pandemie: Gefährliche Angst vor dem Virus
Policies fall short on expanding access to birth control
Was bleibt vom Applaus für die Krankenhäuser?
Unique tool paves the way for more individualized cancer treatments
„Leere Klinikambulanzen“? KBV-Vorstand wundert sich über Selbstwahrnehmung der DKG
French feminists criticise choice of justice, interior ministers over sexism and rape claims
Can the Trauma of War Lead to Growth, Despite the Scars?
Better treatment for people with inflammatory bowel disease
New app launched to battle swarms
Hoher Cholesterinspiegel? Besser Kohlenhydrate sparen als ungesättigte Fettsäuren
Deutsche Bank fined $150 million for failing to flag Jeffrey Epstein accounts
Novavax Gets $1.6 Billion for Coronavirus Vaccine From Operation Warp Speed
Researchers create air filter that can kill the coronavirus
Covid-19 pandemic accelerating and global peak still to come, WHO says
Nicht invasive Diagnostik bei Verdacht auf KHK: IQWiG sieht aussagekräftige Evidenz
Brazil's President Bolsonaro tests positive for coronavirus
‘It Will Consume Your Life’: 4 Families Take On Rare Diseases
Europe coronavirus deaths top 200,000
Libya’s civil war leaves Sahara community without gas, electricity or water
Hilfe bei Diabetes - Biermann Medizin
Live Coronavirus Updates: Testing Demand in U.S. Soars
Types of flu people encounter in childhood may affect susceptibility to different flu strains later ...
Aerobes Training am Morgen bessert Schlaf nach Herz-Bypass
Patient Is Reported Free of H.I.V., but Scientists Urge Caution
One million epilepsy patients in China missing out on beneficial surgery
Wegweiser für die Wundheilung: Erstmals Kleeblattpeptid synthetisiert
A Shot to Protect Against H.I.V.
Improved cancer immunotherapies require radical CAR overhaul
Accident or sabotage? What we know of incident at Iran's Natanz nuclear site
Rheuma: Herz und Gefäße leiden oft mit
Mumbai opens new hospitals as India virus deaths top 20,000
Star lawyer Dupond-Moretti named justice minister in French reshuffle surprise
BÄK-Präsident Reinhardt fordert "Digitalisierungsschub" - Biermann Medizin
Fighting E. coli with E. coli
Atypische Kehlkopfinfektionen - Biermann Medizin
French economy to shrink 10% as EU forecasts deeper hit from Covid-19
View mask refusers like drink drivers: leading scientist
Second Act: Will Macron reshuffle set a new course?
Alzheimer: Abnormale Proteine wandern vom Darm ins Gehirn
Italy's La Scala opera house reopens after four-month shutdown
Beijing reports zero virus cases for first time since new outbreak
TikTok to exit Hong Kong market as security law curbs online freedoms
Universität Halle-Wittenberg: Dierks verstärkt Krebsforschung
Australia's second-biggest city under new virus lockdown
Das Human Brain Project startet in die finale Phase
Israel reimposes restrictions amid new surge in coronavirus cases
Johnson and Johnson cuts price of anti-TB tablets
High-End-Mikroskopie weiter verfeinert
How Safe Are Outdoor Gatherings?
Most primary care providers screening toddlers for autism
Airborne Coronavirus: What You Should Do Now
Health expenditures considerable for asthma, COPD in U.S. workers
WHO reviewing study on concerns over airborne spread of Covid-19
A New Generation of Coronavirus Tests Is Coming. Here's What to Expect.
With pandemic-related stress, abuse against kids can surge
In Nick Cordero’s Death, a Reminder of Covid-19’s Unknowns
Pompeo calls China's censorship moves in Hong Kong 'Orwellian'
Will the COVID-19 pandemic leave a mental health crisis in its wake?
China gives Hong Kong police sweeping security surveillance powers under new law
Months after infection, many COVID-19 patients can't shake illness
US says foreign students whose classes move online due to Covid-19 have to leave
Brazil's Bolsonaro takes Covid-19 test after showing symptoms
Coronavirus ups anxiety, depression in the LGBTQ community

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Heart failure patients with limited health literacy may have higher risk of death

Mon May 25 , 2020
Human heart. Credit: copyright American Heart Association Patients with heart failure who experience low health literacy are at an increased risk of hospitalization and mortality. This finding has significant clinical and public health implications and suggests that assessing and intervening upon an individual’s understanding of their own health could improve […]